z-logo
open-access-imgOpen Access
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir
Author(s) -
Josep M Llibre,
Peré Domingo,
Rosario Palacios,
Jesús Santos,
María Jesús Pérez Elías,
Rainel Sánchez-de la Rosa,
Celia Miralles,
Antonio Antela,
Santiago Moreno
Publication year - 2006
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/01.aids.0000233574.49220.de
Subject(s) - stavudine , medicine , adverse effect , lipid profile , cholesterol , gastroenterology , prospective cohort study , human immunodeficiency virus (hiv) , endocrinology , viral load , antiretroviral therapy , immunology
To describe the 12-month evolution of lipid profile in HIV-infected virologically suppressed patients substituting tenofovir for stavudine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here